BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27365493)

  • 41. Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts.
    Akintoye E; Afonso L; Bengaluru Jayanna M; Bao W; Briasoulis A; Robinson J
    J Am Heart Assoc; 2021 Jun; 10(12):e019589. PubMed ID: 34092110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neural network-based integration of polygenic and clinical information: development and validation of a prediction model for 10-year risk of major adverse cardiac events in the UK Biobank cohort.
    Steinfeldt J; Buergel T; Loock L; Kittner P; Ruyoga G; Zu Belzen JU; Sasse S; Strangalies H; Christmann L; Hollmann N; Wolf B; Ference B; Deanfield J; Landmesser U; Eils R
    Lancet Digit Health; 2022 Feb; 4(2):e84-e94. PubMed ID: 35090679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients.
    Fransen van de Putte DE; Fischer K; Makris M; Tait RC; Chowdary P; Collins PW; Meijer K; Roosendaal G; Schutgens RE; Mauser-Bunschoten EP
    Thromb Haemost; 2013 Jan; 109(1):16-23. PubMed ID: 23138324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank.
    Welsh C; Welsh P; Celis-Morales CA; Mark PB; Mackay D; Ghouri N; Ho FK; Ferguson LD; Brown R; Lewsey J; Cleland JG; Gray SR; Lyall DM; Anderson JJ; Jhund PS; Pell JP; McGuire DK; Gill JMR; Sattar N
    Diabetes Care; 2020 Feb; 43(2):440-445. PubMed ID: 31852727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community.
    Kaess BM; Preis SR; Lieb W; Beiser AS; Yang Q; Chen TC; Hengstenberg C; Erdmann J; Schunkert H; Seshadri S; Vasan RS; ; Assimes TL; Deloukas P; Holm H; Kathiresan S; König IR; McPherson R; Reilly MP; Roberts R; Samani NJ; Stewart AF
    J Am Heart Assoc; 2015 Mar; 4(3):e001544. PubMed ID: 25762803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement in Cardiovascular Risk Prediction with Electronic Health Records.
    Pike MM; Decker PA; Larson NB; St Sauver JL; Takahashi PY; Roger VL; Rocca WA; Miller VM; Olson JE; Pathak J; Bielinski SJ
    J Cardiovasc Transl Res; 2016 Jun; 9(3):214-222. PubMed ID: 26960568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of Left Ventricular Mass and Geometry for Determining 10-Year Prediction of Cardiovascular Disease in Adults Aged >65 Years (from the Cardiovascular Health Study).
    Desai CS; Bartz TM; Gottdiener JS; Lloyd-Jones DM; Gardin JM
    Am J Cardiol; 2016 Sep; 118(5):684-90. PubMed ID: 27457431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study.
    Barzegar N; Tohidi M; Hasheminia M; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2020 Sep; 19(1):155. PubMed ID: 32993633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 38016710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?
    Simmons RK; Sharp S; Boekholdt SM; Sargeant LA; Khaw KT; Wareham NJ; Griffin SJ
    Arch Intern Med; 2008 Jun; 168(11):1209-16. PubMed ID: 18541829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.
    Arts EE; Popa C; Den Broeder AA; Semb AG; Toms T; Kitas GD; van Riel PL; Fransen J
    Ann Rheum Dis; 2015 Apr; 74(4):668-74. PubMed ID: 24389293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic susceptibility, plant-based dietary patterns, and risk of cardiovascular disease.
    Heianza Y; Zhou T; Sun D; Hu FB; Manson JE; Qi L
    Am J Clin Nutr; 2020 Jul; 112(1):220-228. PubMed ID: 32401300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis.
    Yeboah J; Folsom AR; Burke GL; Johnson C; Polak JF; Post W; Lima JA; Crouse JR; Herrington DM
    Circulation; 2009 Aug; 120(6):502-9. PubMed ID: 19635967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of esophageal cancer risk based on genetic variants and environmental risk factors in Chinese population.
    Liu H; Li K; Xia J; Zhu J; Cheng Y; Zhang X; Ye H; Wang P
    BMC Cancer; 2024 May; 24(1):598. PubMed ID: 38755535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of T-wave abnormalities with major cardiovascular events in diabetes: the ACCORD trial.
    Mould SJ; Soliman EZ; Bertoni AG; Bhave PD; Yeboah J; Singleton MJ
    Diabetologia; 2021 Mar; 64(3):504-511. PubMed ID: 33420509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycated hemoglobin measurement and prediction of cardiovascular disease.
    ; Di Angelantonio E; Gao P; Khan H; Butterworth AS; Wormser D; Kaptoge S; Kondapally Seshasai SR; Thompson A; Sarwar N; Willeit P; Ridker PM; Barr EL; Khaw KT; Psaty BM; Brenner H; Balkau B; Dekker JM; Lawlor DA; Daimon M; Willeit J; Njølstad I; Nissinen A; Brunner EJ; Kuller LH; Price JF; Sundström J; Knuiman MW; Feskens EJ; Verschuren WM; Wald N; Bakker SJ; Whincup PH; Ford I; Goldbourt U; Gómez-de-la-Cámara A; Gallacher J; Simons LA; Rosengren A; Sutherland SE; Björkelund C; Blazer DG; Wassertheil-Smoller S; Onat A; Marín Ibañez A; Casiglia E; Jukema JW; Simpson LM; Giampaoli S; Nordestgaard BG; Selmer R; Wennberg P; Kauhanen J; Salonen JT; Dankner R; Barrett-Connor E; Kavousi M; Gudnason V; Evans D; Wallace RB; Cushman M; D'Agostino RB; Umans JG; Kiyohara Y; Nakagawa H; Sato S; Gillum RF; Folsom AR; van der Schouw YT; Moons KG; Griffin SJ; Sattar N; Wareham NJ; Selvin E; Thompson SG; Danesh J
    JAMA; 2014 Mar; 311(12):1225-33. PubMed ID: 24668104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of the clinical utility of adding common single nucleotide polymorphism genetic scores to classical risk factor algorithms in coronary heart disease risk prediction in UK men.
    Beaney KE; Cooper JA; Drenos F; Humphries SE
    Clin Chem Lab Med; 2017 Aug; 55(10):1605-1613. PubMed ID: 28586300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
    Figueroa AL; Abdelbaky A; Truong QA; Corsini E; MacNabb MH; Lavender ZR; Lawler MA; Grinspoon SK; Brady TJ; Nasir K; Hoffmann U; Tawakol A
    JACC Cardiovasc Imaging; 2013 Dec; 6(12):1250-9. PubMed ID: 24269261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous metabolic syndrome risk score for predicting cardiovascular disease in the Chinese population.
    Kang GD; Guo L; Guo ZR; Hu XS; Wu M; Yang HT
    Asia Pac J Clin Nutr; 2012; 21(1):88-96. PubMed ID: 22374565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic predisposition to higher blood pressure increases risk of incident hypertension and cardiovascular diseases in Chinese.
    Lu X; Huang J; Wang L; Chen S; Yang X; Li J; Cao J; Chen J; Li Y; Zhao L; Li H; Liu F; Huang C; Shen C; Shen J; Yu L; Xu L; Mu J; Wu X; Ji X; Guo D; Zhou Z; Yang Z; Wang R; Yang J; Yan W; Gu D
    Hypertension; 2015 Oct; 66(4):786-92. PubMed ID: 26283040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.